Our lab is dedicated to understand the interactions between microbes and the host at mucosal surfaces. We are interested in applying this knowledge to prevent and treat human and veterinary diseases. We want to understand how diet, microbiota, metabolism and immunity interact in health and disease. Currently we are 80% located at the ETH Zürich, and 20% in Oxford, with research running in both locations.
The interactions between diet, the microbiota and the host immune system
Safe and effective vaccines for application in livestock rearing.
Mechanistic understanding of food-as-therapy for microbiota/immunity-related diseases.
Our current understanding of microbiota population dynamics in the gut is based on the sequencing data or the quantification of certain strains by culture.
Claudia Eberl, Diana Ring, Philipp C. Münch, Markus Beutler, Marijana Basic, Emma C. Slack, Martin Schwarzer, Dagmar Srutkova, Anna Lange, Julia S. Frick, André Bleich and Bärbel Stecher
Frontiers in Microbiology, vol. 10, pp. 2999, Lausanne: Fontiers Research Foundation, 2020.
Claudia Eberl, Diana Ring, Philipp C. Münch, Markus Beutler, Marijana Basic, Emma C. Slack, Martin Schwarzer, Dagmar Srutkova, Anna Lange, Julia S. Frick, André Bleich and Bärbel Stecher
Frontiers in Microbiology, vol. 10, pp. 2999, Lausanne: Fontiers Research Foundation, 2020.
Oliver Pabst and Emma Slack
Mucosal Immunology, vol. 13: no. 1, pp. 12-21, New York, NY: Nature Publishing Group, 2020
Daniel Hoces, Markus Arnoldini, Médéric Diard, Claude Loverdo and Emma Wetter Slack
Immunology, vol. 159: no. 1, pp. 52-62, Hoboken, NJ: Wiley, 2020
Postdoctoral Researcher
Medical Science Liaison, Novartis (Japan)
Clinical Research Manager, Novartis (Switzerland)
Research Assistant, Igis (Switzerland)
Master Student, Ludwig Maximilian University, Munich
Migros Industry Management Trainee (Switzerland)
Research Associate, Roche (Switzerland)
Scientist, Roche (Switzerland)
Medical Student, ETH Zurich
PhD Candidate, MRC Laboratory of Molecular Biology (Cambridge, England)
Clinical Research Associate II, AO Foundation (Switzerland)
Radio Oncology Research Technician, University Hospital Zurich
Mechanical Engineer, Ypsomed AG, Burgdorf
PhD Student, University of Sorbonne (France)
Analyst, Xlife Sciences
PhD Candidate, Université Côte d’Azur, Nice
Master Student, ETH Zurich
Master Student, ETH Zurich
Master Student, ETH Zurich
Biomedical Scientist, University Hospital Balgrist, Zurich
Intern, EPFL
Master Student, ETH Zurich
Master Student, ETH Zurich
Intern, Swiss Federal Food Safety and Veterinary Office
Trainee, Nestlé (Switzerland)
Medical Student, ETH Zurich
Master Student, ETH Zurich
PhD Student, Saarland University (Germany)
Master Student, ETH Zurich
Master Student, ETH Zurich
Master Student, ETH Zurich
Master Student, ETH Zurich
Bachelor Student, ETH Zurich
Teacher
Interview from the Swiss Young Immunologist Society with Emma. Learn about Emma's passion for immunology, why Emma wanted to become a scientist and how diversity can benefit science.
Check out the latest video from the Botnar Research Centre for Child Health (BRCCH) introducing the multi-investigator research project led by Prof Emma Slack, ETH Zurich. Two very serious diseases of newborns – namely, inborn errors of metabolism and neonatal sepsis – currently have high mortality rates, long-term consequences for child development and limited treatment options. The project seeks to develop novel intervention strategies for these diseases using advancements in microbiota bioengineering.
Have a look at the video of the BRCCH introducing itself and its mission. It also includes some insights into the different research projects that have received funding in their multi-investigator project call in 2019.
Watch the SRF Puls coverage on our research on Corona virus vaccines.
Schädliche Darmbakterien mutieren und machen uns so das Leben schwer. Doch die Mutationen könnten ihnen auch zum Verhängnis werden.
Intestinal antibodies (IgA) can exert selective pressure on intestinal bacteria. Via oral vaccines, we can manipulate these selective pressures to force evolution of Salmonella that are impaired in transmitting disease. This new vaccination strategy could be used to prevent disease caused by antibiotic-resistant intestinal bacteria.